Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)
Clinical trial NCT06311214 · RECRUITING
Trial details
- NCT number
- NCT06311214
- Sponsor
- National Cancer Institute (NCI)
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-18
- Primary completion
- 2028-03-31
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.